Stay updated on Tresiba Long-term Use Post-marketing Clinical Trial
Sign up to get notified when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.

Latest updates to the Tresiba Long-term Use Post-marketing Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page shows a new footer revision tag 'Revision: v3.3.3' and removal of the 'HHS Vulnerability Disclosure' link, along with the preceding 'Revision: v3.3.2' tag. These are surface-level maintenance updates not affecting core content or user-facing functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page.SummaryDifference0.1%

- Check46 days agoChange DetectedThe government funding/operating-status notice at the top of the page was removed; this means the page no longer warns that updates may be delayed, while core study details remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check61 days agoChange DetectedPage layout and header spacing were refreshed; all sections (Overview, Eligibility Criteria, Study Plan, Contacts) remain present and unchanged in content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check89 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference6%

- Check96 days agoChange DetectedUpdated the page from Revision: v3.0.2 to Revision: v3.1.0, signaling a new release version.SummaryDifference0.1%

Stay in the know with updates to Tresiba Long-term Use Post-marketing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tresiba Long-term Use Post-marketing Clinical Trial page.